Influence of physical activity on active surveillance discontinuation in men with low-risk prostate cancer

被引:5
作者
Papadopoulos, Efthymios [1 ,2 ]
Alibhai, Shabbir M. H. [2 ,3 ,4 ]
Tomlinson, George A. [3 ,4 ,6 ]
Matthew, Andrew G. [3 ,4 ]
Nesbitt, Michael [5 ]
Finelli, Antonio [3 ,5 ]
Trachtenberg, John [3 ,5 ]
Santa Mina, Daniel [1 ,2 ,3 ]
机构
[1] Univ Toronto, Fac Kinesiol & Phys Educ, Toronto, ON, Canada
[2] Princess Margaret Canc Ctr, Dept Support Care, Toronto, ON, Canada
[3] Univ Toronto, Fac Med, Toronto, ON, Canada
[4] Univ Hlth Network, Dept Med, Toronto, ON, Canada
[5] Princess Margaret Canc Ctr, Dept Surg Oncol, Div Urol, Toronto, ON, Canada
[6] Univ Toronto, Inst Hlth Policy Management & Evaluat, Toronto, ON, Canada
关键词
Prostate cancer; Low-risk disease; Active surveillance; Physical activity; Treatment; EXERCISE; LIFE;
D O I
10.1007/s10552-019-01211-0
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Purpose Epidemiologic data suggest that high levels of physical activity (PA) may reduce the risk of disease progression in men with prostate cancer (PCa), but it is unknown whether PA can delay the requirement for definitive treatment for those on active surveillance (AS). We investigated the influence of PA post-diagnosis on AS discontinuation in men with low-risk disease. Methods The effect of PA on the time to AS discontinuation was assessed in 421 patients, of whom 107 underwent additional PCa treatment over a median of 2.5 years. Results Using Cox regression models, we found that PA was not significantly associated with time to curative treatment initiation. Prostate-specific antigen (PSA) most proximal to AS initiation (HR, 1.11; 95% CI 1.03 to 1.21) and the number of positive cores (HR, 1.34; 95% CI 1.12 to 1.61) at diagnosis were associated with a significantly increased risk of discontinuing AS. Conclusion Our findings suggest that PA during AS for PCa does not significantly influence time to curative treatment.
引用
收藏
页码:1009 / 1012
页数:4
相关论文
共 50 条
  • [41] A single centre experience of active surveillance as management strategy for low-risk prostate cancer in Ireland
    Forde, J. C.
    Daly, P. J.
    White, S.
    Morrin, M.
    Smyth, G. P.
    O'Neill, B. D. P.
    Power, R. E.
    IRISH JOURNAL OF MEDICAL SCIENCE, 2014, 183 (03) : 377 - 382
  • [42] Predictors of adverse pathology on radical prostatectomy specimen in men initially enrolled in active surveillance for low-risk prostate cancer
    Bjornebo, Lars
    Olsson, Henrik
    Nordstrom, Tobias
    Jaderling, Fredrik
    Gronberg, Henrik
    Eklund, Martin
    Lantz, Anna
    WORLD JOURNAL OF UROLOGY, 2021, 39 (06) : 1797 - 1804
  • [43] Evolving indications for active surveillance in low-risk localized prostate cancer
    Carroll, PR
    Cooperberg, MR
    EUROPEAN UROLOGY SUPPLEMENTS, 2003, 2 (09) : 7 - 13
  • [44] Predictors of adverse pathology on radical prostatectomy specimen in men initially enrolled in active surveillance for low-risk prostate cancer
    Lars Björnebo
    Henrik Olsson
    Tobias Nordström
    Fredrik Jäderling
    Henrik Grönberg
    Martin Eklund
    Anna Lantz
    World Journal of Urology, 2021, 39 : 1797 - 1804
  • [45] Active Surveillance for Low-Risk Prostate Cancer Worldwide: The PRIAS Study
    Bul, Meelan
    Zhu, Xiaoye
    Valdagni, Riccardo
    Pickles, Tom
    Kakehi, Yoshiyuki
    Rannikko, Antti
    Bjartell, Anders
    van der Schoot, Deric K.
    Cornel, Erik B.
    Conti, Giario N.
    Boeve, Egbert R.
    Staerman, Frederic
    Vis-Maters, Jenneke J.
    Vergunst, Henk
    Jaspars, Joris J.
    Stroelin, Petra
    van Muilekom, Erik
    Schroder, Fritz H.
    Bangma, Chris H.
    Roobol, Monique J.
    EUROPEAN UROLOGY, 2013, 63 (04) : 597 - 603
  • [46] Should men with low-risk, localized prostate cancer choose active surveillance or undergo a robotic prostatectomy?
    Peter Albertsen
    Current Urology Reports, 2008, 9 (1) : 1 - 2
  • [47] Active surveillance for low-risk prostate cancer in Austria: the online registry of the Qualitätspartnerschaft Urologie (QuapU)
    Klaus Eredics
    Karl Dorfinger
    Gero Kramer
    Anton Ponholzer
    Stephan Madersbacher
    Wiener klinische Wochenschrift, 2017, 129 : 375 - 379
  • [48] Active Surveillance for Low-risk Prostate Cancer: The European Association of Urology Position in 2018
    Briganti, Alberto
    Fossati, Nicola
    Catto, James W. F.
    Cornford, Philip
    Montorsi, Francesco
    Mottet, Nicolas
    Wirth, Manfred
    Van Poppel, Hendrik
    EUROPEAN UROLOGY, 2018, 74 (03) : 357 - 368
  • [49] Active surveillance in low risk prostate cancer
    Bozkurt, Ozan
    Demir, Omer
    UROONKOLOJI BULTENI-BULLETIN OF UROONCOLOGY, 2013, 12 (02): : 76 - 79
  • [50] The role of prostate-specific antigen density in men with low-risk prostate cancer suitable for active surveillance: results of a prospective observational study
    Sebastianelli, Arcangelo
    Morselli, Simone
    Vitelli, Ferdinando Daniele
    Gabellini, Linda
    Tasso, Giovanni
    Venturini, Stefano
    Cito, Gianmartin
    Vignolini, Graziano
    Raspollini, Maria Rosaria
    Gacci, Mauro
    Serni, Sergio
    PROSTATE INTERNATIONAL, 2019, 7 (04) : 139 - 142